SCHEMBL8129666

SCHEMBL8129666

CCCCCC(CC(=O)Nc1cc(C(N)=O)ccc1C(C)(C)C)c1ccc(C)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
GAA P10253 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
KMT2A Q03164 2/20 0.40
LPAR1 Q92633 7/20 0.36
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
ERAP2 Q6P179 1/20 0.34
LNPEP Q9UIQ6 1/20 0.34
HTT P42858 1/20 0.33
MRGPRX1 Q96LB2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8143793 0.92 L3MBTL1 (0.41) L3MBTL1GAATDP1LPAR1ALDH1A1
SCHEMBL8129465 0.92 L3MBTL1 (0.42) L3MBTL1GAATDP1KMT2ALPAR1
SCHEMBL8131624 0.92 L3MBTL1 (0.42) L3MBTL1GAATDP1KMT2ALPAR1
SCHEMBL8129254 0.91 L3MBTL1 (0.40) L3MBTL1GAATDP1KMT2AMAPK1
SCHEMBL8128937 0.91 KMT2A (0.40) L3MBTL1KMT2AMAPK1
SCHEMBL8119996 0.91 LPAR1 (0.41) L3MBTL1KMT2ALPAR1MAPK1ALDH1A1
SCHEMBL8129705 0.91 L3MBTL1 (0.40) L3MBTL1GAATDP1KMT2AMAPK1
SCHEMBL8131084 0.91 LPAR1 (0.41) L3MBTL1GAATDP1KMT2ALPAR1
SCHEMBL8130312 0.91 KMT2A (0.39) L3MBTL1GAATDP1KMT2AMAPK1
SCHEMBL8127088 0.90 L3MBTL1 (0.42) L3MBTL1GAATDP1KMT2ALPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed